Sponsor or institution

Clinical trials and research at Kriya Therapeutics, Inc.

• 6Clinical trials
• 5Countries

Newest trials

All recruiting trials (6)

• VV-14300: a gene therapy approach for adults with type 1 diabetes not well controlled on an automated insulin system

  This trial tests VV-14300 in adults with type 1 diabetes who aren’t reaching their blood sugar goals despite using an automated insulin delivery system.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Toronto and 1 other locations · NCT07831798

• New gene therapies VV-14299 and VV-14300 for adults with Type 1 Diabetes failing automated insulin delivery

  This study tests VV-14299 and VV-14300, or VV-14300 alone, in adults with long-standing Type 1 Diabetes whose blood sugar remains poorly controlled despite using an automated insulin delivery system.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Melbourne · NCT07829302

• VV-14303 for metabolic liver disease in adults with MASH

  This study tests VV-14303, a gene therapy, in adults with metabolic dysfunction-associated steatohepatitis (MASH) to see if it is safe and how well it works.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Chandler, Arizona and 2 other locations · NCT07732400

• RP-008 with daily varenicline for trigeminal neuralgia

  A new treatment approach tests RP-008 together with varenicline to see if it is safe, tolerable, and offers pain relief for adults with trigeminal neuralgia.

  Recruiting Phase 1/2 Kriya Therapeutics, Inc. · Sherbrooke · NCT07596485

• KRIYA-586 (VV-14305) for Thyroid Eye Disease

  Aimed at adults with thyroid eye disease, the study tests whether VV-14305 can be safely given and help improve eye symptoms.

  Recruiting at 5 sites Phase 1/2 Kriya Therapeutics, Inc. · Livonia, Michigan and 4 other locations · NCT07404111

• Evaluating KRIYA-825 for treating geographic atrophy in older adults

  This study is testing a new treatment called KRIYA-825 to see if it can safely help older adults with geographic atrophy from age-related macular degeneration by slowing down the growth of eye lesions.

  Recruiting at 4 sites Phase 1/2 Kriya Therapeutics, Inc. · Erie, Pennsylvania and 3 other locations · NCT06765980

Quick answers

How many clinical trials run by Kriya Therapeutics, Inc. are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in New Zealand (4 trials), United States (3 trials), Canada (3 trials), Israel (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 6. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →